Senior scientific and technical executive with more than three decades of leadership across computational biology, molecular neurobiology, pharmacogenomics, AI-enabled medical technology, translational medicine, medical simulation, and healthcare innovation. Career contributions include foundational Alzheimer’s disease molecular biology, early regulated machine-learning medical imaging, FDA-reviewed diagnostic technology, pharmacogenomic clinical decision support, electronic health-record innovation, and AI-first precision-medicine platforms. -126 peer-reviewed publications, H-index of 41 -13 published patents Product development: • GeneSight® psychotropic pharmacogenomic diagnostic test; acquired by Myriad Genetics. • GenomeQuest® sequence patent search engine; acquired by Monsanto. • Azyxxi electronic health record; acquired by Microsoft Health Solutions. • Virtual I.V. simulation system with haptics and 3D graphics; acquired by Laerdal Medical Corporation. • Roche AutoCyte Pap-smear imaging using convolutional neural networks; acquired by Becton Dickinson.